208 related articles for article (PubMed ID: 15364708)
21. Treatment with 9-cis β-carotene-rich powder in patients with retinitis pigmentosa: a randomized crossover trial.
Rotenstreich Y; Belkin M; Sadetzki S; Chetrit A; Ferman-Attar G; Sher I; Harari A; Shaish A; Harats D
JAMA Ophthalmol; 2013 Aug; 131(8):985-92. PubMed ID: 23700011
[TBL] [Abstract][Full Text] [Related]
22. Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 study.
Souied EH; Delcourt C; Querques G; Bassols A; Merle B; Zourdani A; Smith T; Benlian P;
Ophthalmology; 2013 Aug; 120(8):1619-31. PubMed ID: 23395546
[TBL] [Abstract][Full Text] [Related]
23. Effect of docosahexaenoic acid supplementation on the macular function of patients with Best vitelliform macular dystrophy: randomized clinical trial.
Lee TK; Clandinin MT; Hébert M; MacDonald IM
Can J Ophthalmol; 2010 Oct; 45(5):514-9. PubMed ID: 20847757
[TBL] [Abstract][Full Text] [Related]
24. [Influence of docosahexaenoic acid treatment on visual acuity, visual field and bioelectric potential of the retina in patients with retinitis pigmentosa].
Sheludchenko VM
Vestn Oftalmol; 2020; 136(4. Vyp. 2):296-299. PubMed ID: 32880154
[TBL] [Abstract][Full Text] [Related]
25. Investigation of the effect of dietary docosahexaenoic acid (DHA) supplementation on macular function in subjects with autosomal recessive Stargardt macular dystrophy.
MacDonald IM; Sieving PA
Ophthalmic Genet; 2018 Aug; 39(4):477-486. PubMed ID: 29912604
[TBL] [Abstract][Full Text] [Related]
26. Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289].
Bahrami H; Melia M; Dagnelie G
BMC Ophthalmol; 2006 Jun; 6():23. PubMed ID: 16759390
[TBL] [Abstract][Full Text] [Related]
27. Docosahexaenoic acid in red blood cells of patients with X-linked retinitis pigmentosa.
Hoffman DR; Birch DG
Invest Ophthalmol Vis Sci; 1995 May; 36(6):1009-18. PubMed ID: 7730010
[TBL] [Abstract][Full Text] [Related]
28. Slowing the degenerative process, long lasting effect of hyperbaric oxygen therapy in retinitis pigmentosa.
Vingolo EM; Rocco M; Grenga P; Salvatore S; Pelaia P
Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):93-8. PubMed ID: 17674017
[TBL] [Abstract][Full Text] [Related]
29. Letter from the DSMC regarding a clinical trial of lutein in patients with retinitis pigmentosa.
Wittes J; Gorin MB; Mayne ST; McCarthy CS; Sternberg P; Wall M
Arch Ophthalmol; 2011 May; 129(5):675; author reply 675-6. PubMed ID: 21555632
[No Abstract] [Full Text] [Related]
30. How strong is the evidence that nutritional supplements slow the progression of retinitis pigmentosa?
Massof RW; Fishman GA
Arch Ophthalmol; 2010 Apr; 128(4):493-5. PubMed ID: 20385948
[No Abstract] [Full Text] [Related]
31. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet.
Dagnelie G; Zorge IS; McDonald TM
Optometry; 2000 Mar; 71(3):147-64. PubMed ID: 10970259
[TBL] [Abstract][Full Text] [Related]
32. Test-retest reliability of the multifocal electroretinogram and humphrey visual fields in patients with retinitis pigmentosa.
Seiple W; Clemens CJ; Greenstein VC; Carr RE; Holopigian K
Doc Ophthalmol; 2004 Nov; 109(3):255-72. PubMed ID: 15957611
[TBL] [Abstract][Full Text] [Related]
33. A randomized placebo-controlled clinical trial of docosahexaenoic acid (DHA) supplementation for X-linked retinitis pigmentosa.
Birch DG
Retina; 2005 Dec; 25(8 Suppl):S52-S54. PubMed ID: 16374336
[No Abstract] [Full Text] [Related]
34. Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results.
Arslan U; Özmert E; Demirel S; Örnek F; Şermet F
Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):893-908. PubMed ID: 29546474
[TBL] [Abstract][Full Text] [Related]
35. Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations.
Berson EL; Rosner B; Weigel-DiFranco C; Dryja TP; Sandberg MA
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3027-36. PubMed ID: 12202526
[TBL] [Abstract][Full Text] [Related]
36. Improvement of central retinal sensitivity six months after topical isopropyl unoprostone in patients with retinitis pigmentosa.
Tawada A; Sugawara T; Ogata K; Hagiwara A; Yamamoto S
Indian J Ophthalmol; 2013 Mar; 61(3):95-9. PubMed ID: 23514642
[TBL] [Abstract][Full Text] [Related]
37. The relationship between visual disability and visual scores in patients with retinitis pigmentosa.
Sumi I; Matsumoto S; Okajima O; Shirato S
Jpn J Ophthalmol; 2000; 44(1):82-7. PubMed ID: 10698030
[TBL] [Abstract][Full Text] [Related]
38. Visual Function in Carriers of X-Linked Retinitis Pigmentosa.
Comander J; Weigel-DiFranco C; Sandberg MA; Berson EL
Ophthalmology; 2015 Sep; 122(9):1899-906. PubMed ID: 26143542
[TBL] [Abstract][Full Text] [Related]
39. Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adults.
Gold DR; Litonjua AA; Carey VJ; Manson JE; Buring JE; Lee IM; Gordon D; Walter J; Friedenberg G; Hankinson JL; Copeland T; Luttmann-Gibson H
Contemp Clin Trials; 2016 Mar; 47():185-95. PubMed ID: 26784651
[TBL] [Abstract][Full Text] [Related]
40. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
Age-Related Eye Disease Study Research Group
Arch Ophthalmol; 2001 Oct; 119(10):1417-36. PubMed ID: 11594942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
